The growth and global spread of infections resistant to almost all known antibiotics is a huge looming threat. A recent study estimates up to 10 million lives could be lost each year by 2050, with enormous economic impact. Antimicrobial resistance could reverse progress made against big global killers such as HIV, malaria and tuberculosis. Even common surgery could carry a lethal risk of infection.
CGD work examines the incentives, innovation, and impetus needed to ensure collective action to produce a new generation of antibiotics, and encourage their widespread development and use.